window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 29, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Veristat

  • Clinical Development,Data Management,Mergers & Acquisitions,Regulatory Affairs,Research & Development

    Veristat acquires Certara regulatory and medical writing business

    Veristat has agreed to acquire Certara’s regulatory and medical writing [...]

    April 22, 2026
  • Biotech,Clinical Development,Clinical studies,Clinical Trials,Healthcare leadership,Movers & Shakers,Rare Diseases

    Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth

    Veristat, a global clinical research organization (CRO) and consultancy specializing [...]

    January 15, 2026
  • Biotech,Clinical studies,Clinical Trials,Pharmaceuticals and therapeutics

    Veristat and AOBiome to discuss strategic CRO partnerships at Clinical Outsourcing Group 2025

    Veristat, a global clinical research organization (CRO) and consultancy, will [...]

    October 8, 2025
  • Cell & Gene Therapy,Clinical Trials,European biotech,Women in Pharma,Women's Health

    Cook MyoSite and Veristat progress Phase 3 trial of cell therapy for women with chronic incontinence

    Cook MyoSite and Veristat have reached a key enrolment milestone [...]

    September 17, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • SGD Pharma highlights GLP-1 demand, supply chain pressure and sustainability focus at DCAT Week
    Categories: CDMOs & Manufacturing, Healthcare leadership, Market Access & Commercialization, Pharmaceuticals and therapeutics, Supply Chain & Logistics
  • ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development
    Categories: Drug Delivery & Formulation, Drug Development, Oncology, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top